{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:09:21Z","timestamp":1785470961851,"version":"3.56.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1001\/jamadermatol.2018.1408","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T19:30:24Z","timestamp":1526758224000},"page":"781","source":"Crossref","is-referenced-by-count":63,"title":["Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex"],"prefix":"10.1001","volume":"154","author":[{"given":"Mari","family":"Wataya-Kaneda","sequence":"first","affiliation":[{"name":"Department of Dermatology, Graduate School of Medicine, Osaka University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuki","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Dermatology, JR Tokyo General Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Yokozeki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Niizeki","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Surgical Subspecialties, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ogai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Seirei Hamamatsu General Hospital, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Fukai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nagai","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Tottori, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Hamada","sequence":"additional","affiliation":[{"name":"Nobelpharma Co, Ltd, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taihei","family":"Hio","sequence":"additional","affiliation":[{"name":"Nobelpharma Co, Ltd, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Nobelpharma Co, Ltd, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Murota","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medicine, Osaka University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"doi180023r2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaad.2007.05.004","article-title":"Tuberous sclerosis complex: advances in diagnosis, genetics, and management.","volume":"57","author":"Schwartz","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi180023r3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2133.1996.tb03597.x","article-title":"The cutaneous features of tuberous sclerosis: a population study.","volume":"135","author":"Webb","year":"1996","journal-title":"Br J Dermatol"},{"issue":"5","key":"doi180023r4","doi-asserted-by":"publisher","first-page":"e63910","DOI":"10.1371\/journal.pone.0063910","article-title":"Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients.","volume":"8","author":"Wataya-Kaneda","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"doi180023r5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archdermatol.2010.125","article-title":"Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.","volume":"146","author":"Haemel","year":"2010","journal-title":"Arch Dermatol"},{"issue":"4","key":"doi180023r6","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/bjd.2011.165.issue-4","article-title":"A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.","volume":"165","author":"Wataya-Kaneda","year":"2011","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi180023r7","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/bjd.2011.165.issue-4","article-title":"Treatment of facial angiofibromas with topical application of oral rapamycin solution (1 mg mL-1) in two patients with tuberous sclerosis.","volume":"165","author":"Mutizwa","year":"2011","journal-title":"Br J Dermatol"},{"issue":"9","key":"doi180023r8","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1001\/archdermatol.2011.254","article-title":"Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: optimizing a treatment protocol.","volume":"147","author":"DeKlotz","year":"2011","journal-title":"Arch Dermatol"},{"issue":"1","key":"doi180023r9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/ajd.2012.53.issue-1","article-title":"Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients.","volume":"53","author":"Foster","year":"2012","journal-title":"Australas J Dermatol"},{"issue":"1","key":"doi180023r10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3109\/09546634.2010.489598","article-title":"Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin.","volume":"23","author":"Kaufman McNamara","year":"2012","journal-title":"J Dermatolog Treat"},{"issue":"10","key":"doi180023r11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/jdv.2012.26.issue-10","article-title":"Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial angiofibroma.","volume":"26","author":"Salido","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"doi180023r12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D36TB7N61M","article-title":"Facial angiofibromas treated with topical rapamycin: an excellent choice with fast response.","volume":"18","author":"Truchuelo","year":"2012","journal-title":"Dermatol Online J"},{"issue":"1","key":"doi180023r13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s13555-017-0174-5","article-title":"Topical rapamycin for facial angiofibromas in a child with tuberous sclerosis complex (TSC): a case report and long-term follow-up.","volume":"7","author":"Ebrahimi-Fakhari","year":"2017","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"doi180023r14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/ajd.2014.55.issue-1","article-title":"Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: follow up of a pilot study and promising future directions.","volume":"55","author":"Tu","year":"2014","journal-title":"Australas J Dermatol"},{"issue":"6","key":"doi180023r15","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/bjd.12567","article-title":"First left-right comparative study of topical rapamycin vs vehicle for facial angiofibromas in patients with tuberous sclerosis complex.","volume":"169","author":"Tanaka","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi180023r16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2165\/11634580-000000000-00000","article-title":"Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin.","volume":"12","author":"Koenig","year":"2012","journal-title":"Drugs R D"},{"issue":"1","key":"doi180023r17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamadermatol.2016.3545","article-title":"Efficacy and safety of topical sirolimus therapy for facial angiofibromas in the tuberous sclerosis complex: a randomized clinical trial.","volume":"153","author":"Wataya-Kaneda","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"4","key":"doi180023r18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"3","key":"doi180023r19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/ced.1994.19.issue-3","article-title":"Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"doi180023r20","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/bjd.1995.132.issue-6","article-title":"The Children\u2019s Dermatology Life Quality Index (CDLQI): initial validation and practical use.","volume":"132","author":"Lewis-Jones","year":"1995","journal-title":"Br J Dermatol"},{"issue":"9861","key":"doi180023r21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"issue":"9869","key":"doi180023r22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"doi180023r23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"issue":"17","key":"doi180023r24","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis.","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"doi180023r1","unstructured":"National Organization for Rare Disorders (NORD). Tuberous sclerosis. https:\/\/rarediseases.org\/rare-diseases\/tuberous-sclerosis. Accessed December 7, 2016."},{"key":"doi180023r25","unstructured":"Afinitor [package insert]. East Hanover, NJ: Novartis. http:\/\/www.pharma.us.novartis.com\/product\/pi\/pdf\/afinitor.pdf. Accessed January 24, 2017."},{"key":"doi180023r26","unstructured":"Rapamune [package insert]. Philadelphia, PA: Pfizer. http:\/\/labeling.pfizer.com\/showlabeling.aspx?id=139. Accessed January 24, 2018."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2681855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T22:54:38Z","timestamp":1661295278000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.1408"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.1408","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,1]]}}}